Bridgebio Pharma Inc (BBIO)

Cost of Revenue

$47.45M

TTM · Period ending: · USD

BBIO logo

BBIO Cost of Revenue

Latest reported$47.45M
BBIO TTM Cost of Revenue ($0.00 → $47.45M)
High-resolution chart · PNG

BBIO cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bridgebio Pharma Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
47,452,000
36,059,000
28,273,000
14,939,000
8,974,000
5,919,000
3,878,000
2,392,000
2,392,000
2,393,000
2,446,000
2,495,000
2,636,000
2,737,000
3,434,000
4,338,000
5,053,000
4,462,000
3,114,000
1,563,000
109,000
0
0
0
2,500,000
2,500,000
2,500,000
2,500,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.